Plain-English summary
High Court: Retailers may seek judicial review of FDA denials of new tobacco product authorizations
The Supreme Court held that retailers who would sell a new tobacco product but are blocked by the FDA’s denial of authorization can pursue judicial review under the statutory review provision. The Court affirmed the Fifth Circuit and remanded the case.
Why this matters
The ruling clarifies who can go to court to contest FDA decisions about new tobacco products. That affects how FDA decisions are reviewed and could expand the number of parties who can challenge denials, shaping litigation strategy and regulatory checks on agency action.
Who may feel it
- Retailers that sell or would sell e-cigarettes and other new tobacco products
- Tobacco and vaping manufacturers and distributors
- The Food and Drug Administration and its regulatory staff
- Consumers and public-health groups with interest in tobacco product availability and safety
- Lower courts handling judicial-review suits under the tobacco law
Key questions
- Does the judicial-review provision of the Family Smoking Prevention and Tobacco Control Act allow retailers (who would sell a product) to challenge an FDA denial of authorization for a new tobacco product?